{"id":200870,"url":"https://lda.senate.gov/api/v1/clients/200870/?format=json","client_id":12,"name":"NOVAVAX, INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-08-17","registrant":{"id":401104157,"url":"https://lda.senate.gov/api/v1/registrants/401104157/?format=json","house_registrant_id":null,"name":"NOVAVAX, INC","description":"clinical-stage vaccine company","address_1":"21 Firstfield Rd.","address_2":null,"address_3":null,"address_4":null,"city":"Gaithersburg","state":"MD","state_display":"Maryland","zip":"20878","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KELLY CAPPIO","contact_telephone":"+1 240-268-2000","dt_updated":"2026-01-09T11:01:33.825180-05:00"}}